. Les-critères-d, inclusion sont fondés sur les critères de Porto édités par l'ESPGHAN (82) Deux groupes distincts sont constitués : ? le groupe des RCH dites classiques (RCHC)

F. Ordonez, F. Lacaille, and D. Canioni, Pediatric ulcerative colitis associated with autoimmune diseases: A distinct form of inflammatory bowel disease?, Inflammatory Bowel Diseases, vol.111, issue.10, pp.1809-1826, 2012.
DOI : 10.1067/mai.2003.3

E. Benchimol, A. Guttmann, and A. Griffiths, Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data, Gut, vol.58, issue.11, pp.1490-1497, 2009.
DOI : 10.1136/gut.2009.188383

C. Gower-rousseau, F. Vasseur, and M. Fumery, Epidemiology of inflammatory bowel diseases: New insights from a French population-based registry (EPIMAD), Digestive and Liver Disease, vol.45, issue.2, pp.89-94, 2013.
DOI : 10.1016/j.dld.2012.09.005

URL : https://hal.archives-ouvertes.fr/hal-01701899

A. Kornbluth and D. Sachar, Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee, The American Journal of Gastroenterology, vol.4, issue.3, pp.501-524, 2010.
DOI : 10.1016/0016-5085(92)90831-I

P. Henderson, J. Van-limbergen, and D. Wilson, Genetics of childhood-onset inflammatory bowel disease, Inflammatory Bowel Diseases, vol.45, issue.1, pp.346-61, 2011.
DOI : 10.1016/j.freeradbiomed.2008.03.003

R. Lev-tzion and D. Turner, Is pediatric IBD treatment different than in adults, Minerva Gastroenterol Dietol, vol.58, pp.137-50, 2012.

R. Scherr, J. Essers, and H. Hakonarson, Genetic Determinants of Pediatric Inflammatory Bowel Disease: Is Age of Onset Genetically Determined?, Digestive Diseases, vol.27, issue.3, pp.236-245, 2009.
DOI : 10.1159/000228555

C. Gower-rousseau, L. Dauchet, and G. Vernier-massouille, The Natural History of Pediatric Ulcerative Colitis: A Population-Based Cohort Study, The American Journal of Gastroenterology, vol.9, issue.8, pp.2080-2088, 2009.
DOI : 10.1053/gast.1997.v112.pm9178675

C. Jung and J. Hugot, Inflammatory Bowel Diseases: the genetic revolution, Gastroent??rologie Clinique et Biologique, vol.33, pp.123-153, 2009.
DOI : 10.1016/S0399-8320(09)73147-1

A. Thompson and C. Lees, Genetics of ulcerative colitis, Inflammatory Bowel Diseases, vol.7, issue.3, pp.831-879, 2011.
DOI : 10.1038/nri2097

C. Abraham and J. Cho, Inflammatory Bowel Disease, New England Journal of Medicine, vol.361, issue.21, pp.2066-78, 2009.
DOI : 10.1056/NEJMra0804647

V. Annese, A. Piepoli, and A. Latiano, HLA-DRB1 Alleles May Influence Disease Phenotype in Patients With Inflammatory Bowel Disease: A Critical Reappraisal With Review of the Literature, Diseases of the Colon & Rectum, vol.48, issue.1, pp.57-64, 2005.
DOI : 10.1007/s10350-004-0747-0

P. Stokkers, P. Reitsma, and G. Tytgat, HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis, Gut, vol.45, issue.3, pp.395-401, 1999.
DOI : 10.1136/gut.45.3.395

D. Saussure, P. Clerson, P. Prost, and P. , Appendectomy, smoking habits and the risk of developing ulcerative colitis: a case control study in private practice setting, Gastroent??rologie Clinique et Biologique, vol.31, issue.5, pp.493-500, 2007.
DOI : 10.1016/S0399-8320(07)89417-6

M. Rajili?-stojanovi?, F. Shanahan, and F. Guarner, Phylogenetic Analysis of Dysbiosis in Ulcerative Colitis During Remission, Inflammatory Bowel Diseases, vol.48, issue.3, pp.481-489, 2013.
DOI : 10.1038/ismej.2011.109

R. Hansen, R. Russell, and C. Reiff, Microbiota of De-Novo Pediatric IBD: Increased Faecalibacterium Prausnitzii and Reduced Bacterial Diversity in Crohn's But Not in Ulcerative Colitis, The American Journal of Gastroenterology, vol.19, issue.12, 2012.
DOI : 10.1128/AEM.66.5.2263-2266.2000

A. Raza, W. Yousaf, and R. Giannella, Th17 cells: interactions with predisposing factors in the immunopathogenesis of inflammatory bowel disease, Expert Review of Clinical Immunology, vol.2, issue.2, pp.161-169, 2012.
DOI : 10.1159/000262276

W. Strober and I. Fuss, Proinflammatory Cytokines in the Pathogenesis of Inflammatory Bowel Diseases, Gastroenterology, vol.140, issue.6, pp.1756-67, 2011.
DOI : 10.1053/j.gastro.2011.02.016

D. Turner, A. Levine, and J. Escher, Management of Pediatric Ulcerative Colitis, Journal of Pediatric Gastroenterology and Nutrition, vol.55, issue.3, pp.340-61, 2012.
DOI : 10.1097/MPG.0b013e3182662233

D. Turner and A. Griffiths, Acute severe ulcerative colitis in children: A systematic review, Inflammatory Bowel Diseases, vol.37, issue.1, pp.440-449, 2011.
DOI : 10.1097/00005176-200408000-00008

A. Morali, I. Gastin, and F. Thirion, P0721 FECAL CALPROTECTIN AS A MARKER OF INTESTINAL INFLAMMATION IN CHILDREN WITH IBD, THROUGH EVOLUTIONARY STAGES AND UNDER TREATMENT., Journal of Pediatric Gastroenterology and Nutrition, vol.39, issue.Supplement 1, p.331, 2004.
DOI : 10.1097/00005176-200406001-00845

B. Abraham and S. Kane, Fecal Markers: Calprotectin and Lactoferrin, Gastroenterology Clinics of North America, vol.41, issue.2, pp.483-95, 2012.
DOI : 10.1016/j.gtc.2012.01.007

D. Bernardini and D. Laharie, Mucosal healing, Acta Endoscopica, vol.18, issue.SupplIII, pp.123-131, 2013.
DOI : 10.1002/ibd.22917

M. Neurath and S. Travis, Mucosal healing in inflammatory bowel diseases: a systematic review, Gut, vol.61, issue.11, pp.1619-1654, 2012.
DOI : 10.1136/gutjnl-2012-302830

G. Lichtenstein and P. Rutgeerts, Importance of mucosal healing in ulcerative colitis, Inflammatory Bowel Diseases, vol.55, issue.2, pp.338-384, 2010.
DOI : 10.1136/gut.2005.081794

C. Papi, F. Fascì-spurio, and F. Rogai, Mucosal healing in inflammatory bowel disease: Treatment efficacy and predictive factors, Digestive and Liver Disease, vol.45, issue.12, pp.978-85, 2013.
DOI : 10.1016/j.dld.2013.07.006

D. Turner, A. Otley, and D. Mack, Development, Validation, and Evaluation of a Pediatric Ulcerative Colitis Activity Index: A Prospective Multicenter Study, Gastroenterology, vol.133, issue.2
DOI : 10.1053/j.gastro.2007.05.029

T. D. Development, evaluation and application of a pediatric ulcerative colitis activity index (PUCAI) -153p, Th : Philisophy, 2008.

P. Rutgeerts, W. Sandborn, and B. Feagan, Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis, New England Journal of Medicine, vol.353, issue.23, pp.2462-76, 2005.
DOI : 10.1056/NEJMoa050516

S. Travis, D. Schnell, and P. Krzeski, Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS), Gut, vol.61, issue.4, pp.535-577, 2012.
DOI : 10.1136/gutjnl-2011-300486

U. Navaneethan and B. Shen, Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease, Inflammatory Bowel Diseases, vol.5, issue.9, pp.1598-619, 2010.
DOI : 10.1016/j.cgh.2006.10.021

U. Broomé, H. Glaumann, and G. Hellers, Liver disease in ulcerative colitis: an epidemiological and follow up study in the county of Stockholm., Gut, vol.35, issue.1, pp.84-93, 1994.
DOI : 10.1136/gut.35.1.84

U. Broomé, H. Glaumann, and R. Hultcrantz, Liver histology and follow up of 68 patients with ulcerative colitis and normal liver function tests., Gut, vol.31, issue.4, pp.468-72, 1990.
DOI : 10.1136/gut.31.4.468

L. Large-guiheneuf, C. Hugot, J. Faure, and C. , Atteintes pancr??atiques dans les maladies inflammatoires du tube digestif de l???enfant, Archives de P??diatrie, vol.9, issue.5, pp.469-77, 2002.
DOI : 10.1016/S0929-693X(01)00828-4

S. Park, D. Kim, and B. Ye, The Characteristics of Ulcerative Colitis Associated With Autoimmune Pancreatitis, Journal of Clinical Gastroenterology, vol.47, issue.6, pp.520-525, 2013.
DOI : 10.1097/MCG.0b013e31827fd4a2

K. Ravi, S. Chari, and S. Vege, Inflammatory bowel disease in the setting of autoimmune pancreatitis, Inflammatory Bowel Diseases, vol.2, issue.9, pp.1326-1356, 2009.
DOI : 10.2307/3002000

G. Trikudanathan, P. Venkatesh, and U. Navaneethan, Diagnosis and Therapeutic Management of Extra-Intestinal Manifestations of Inflammatory Bowel Disease, Drugs, vol.103, issue.9, pp.2333-2382, 2012.
DOI : 10.1111/j.1572-0241.2008.02052.x

H. Becker, M. Gaubitz, and W. Domschke, Joint involvement in chronic inflammatory bowel disease--current diagnostics and treatment options

E. Gravallese and F. Kantrowitz, Arthritic manifestations of inflammatory bowel disease, Am J Gastroenterol, vol.83, pp.703-712, 1988.

C. Salvarani, G. Fornaciari, and M. Beltrami, Musculoskeletal manifestations in inflammatory bowel disease, European Journal of Internal Medicine, vol.11, issue.4, pp.210-214, 2000.
DOI : 10.1016/S0953-6205(00)00093-5

G. Casella, V. Villanacci, D. Bella, and C. , Pulmonary diseases associated with inflammatory bowel diseases, Journal of Crohn's and Colitis, vol.14, issue.Suppl 2, pp.384-393, 2010.
DOI : 10.1002/ibd.20519

D. Farhi, J. Cosnes, and N. Zizi, Significance of Erythema Nodosum and Pyoderma Gangrenosum in Inflammatory Bowel Diseases, Medicine, vol.87, issue.5, pp.281-93, 2008.
DOI : 10.1097/MD.0b013e318187cc9c

URL : https://hal.archives-ouvertes.fr/hal-00944425

A. Marzano, A. Borghi, and A. Stadnicki, Cutaneous Manifestations in Patients With Inflammatory Bowel Diseases, Inflammatory Bowel Diseases, vol.157, issue.1, pp.213-240, 2014.
DOI : 10.1111/j.1365-2133.2007.08048.x

M. Zippi, R. Pica, D. Nitto, and D. , Biological therapy for dermatological manifestations of inflammatory bowel disease, World Journal of Clinical Cases, vol.1, issue.2, pp.74-82, 2013.
DOI : 10.1001/archderm.143.2.223

A. Lossos, Y. River, and A. Eliakim, Neurologic Aspects of Inflammatory Bowel Disease, Neurology, vol.45, issue.3, pp.416-437, 1995.
DOI : 10.1212/WNL.45.3.416

N. Larusso, B. Shneider, and D. Black, Primary sclerosing cholangitis: Summary of a workshop, Hepatology, vol.6, issue.3, pp.746-64, 2006.
DOI : 10.1016/0016-5085(94)90610-6

S. Saarinen, O. Olerup, and U. Broomé, Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis, The American Journal of Gastroenterology, vol.35, issue.11, pp.3195-3204, 2000.
DOI : 10.1016/S0140-6736(75)91560-3

M. Bueno-de-mesquita, M. Ferrante, and L. Henckaerts, Clustering of (auto)immune diseases with early-onset and complicated inflammatory bowel disease, European Journal of Pediatrics, vol.35, issue.5, pp.575-83, 2009.
DOI : 10.1007/s00431-008-0798-7

E. Loftus, . Jr, G. Harewood, and C. Loftus, PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis, Gut, vol.54, issue.1, pp.91-97, 2005.
DOI : 10.1136/gut.2004.046615

R. Stein and S. Hanauer, Comparative Tolerability of Treatments for Inflammatory Bowel Disease, Drug Safety, vol.126, issue.1, pp.429-477, 2000.
DOI : 10.7326/0003-4819-126-5-199703010-00004

J. Hyams, T. Lerer, and D. Mack, Outcome Following Thiopurine Use in Children With Ulcerative Colitis: A Prospective Multicenter Registry Study, The American Journal of Gastroenterology, vol.133, issue.5, pp.981-988, 2011.
DOI : 10.1053/j.gastro.2007.05.029

M. Verhave, H. Winter, and R. Grand, Azathioprine in the treatment of children with inflammatory bowel disease, The Journal of Pediatrics, vol.117, issue.5, pp.809-823, 1990.
DOI : 10.1016/S0022-3476(05)83349-9

T. Nguyen, D. Vu, and T. Nguyen, Relationship Between Azathioprine Dosage and Thiopurine Metabolites in Pediatric IBD Patients, Therapeutic Drug Monitoring, vol.35, issue.2, pp.251-258, 2013.
DOI : 10.1097/FTD.0b013e318282c3a6

URL : https://hal.archives-ouvertes.fr/hal-01324627

K. Benkov, Y. Lu, and A. Patel, Role of Thiopurine Metabolite Testing and Thiopurine Methyltransferase Determination in Pediatric IBD, Journal of Pediatric Gastroenterology and Nutrition, vol.56, issue.3, pp.333-373, 2013.
DOI : 10.1097/MPG.0b013e3182844705

J. Hyams, L. Damaraju, and M. Blank, Induction and Maintenance Therapy With Infliximab for Children With Moderate to Severe Ulcerative Colitis, Clinical Gastroenterology and Hepatology, vol.10, issue.4, pp.391-400, 2012.
DOI : 10.1016/j.cgh.2011.11.026

J. Hyams, T. Lerer, and A. Griffiths, Outcome Following Infliximab Therapy in Children With Ulcerative Colitis, The American Journal of Gastroenterology, vol.55, issue.6, pp.1430-1436, 2010.
DOI : 10.1038/ajg.2009.759

M. Long, H. Herfarth, and C. Pipkin, Increased Risk for Non-Melanoma Skin Cancer in Patients With Inflammatory Bowel Disease, Clinical Gastroenterology and Hepatology, vol.8, issue.3, pp.268-74, 2010.
DOI : 10.1016/j.cgh.2009.11.024

J. Colombel, W. Sandborn, and W. Reinisch, Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease, New England Journal of Medicine, vol.362, issue.15, pp.1383-95, 2010.
DOI : 10.1056/NEJMoa0904492

L. Yang, A. G. Catto-smith, and A. , The use of biologic agents in pediatric inflammatory bowel disease, Current Opinion in Pediatrics, vol.24, issue.5, pp.609-623, 2012.
DOI : 10.1097/MOP.0b013e3283574154

J. Hyams, J. Markowitz, and T. Lerer, The Natural History of Corticosteroid Therapy for Ulcerative Colitis in Children, Clinical Gastroenterology and Hepatology, vol.4, issue.9, pp.1118-1141, 2006.
DOI : 10.1016/j.cgh.2006.04.008

J. Ezri, P. Marques-vidal, and A. Nydegger, Impact of Disease and Treatments on Growth and Puberty of Pediatric Patients with Inflammatory Bowel Disease, Digestion, vol.85, issue.4, pp.308-327, 2012.
DOI : 10.1159/000336766

S. Barrena, L. Martínez, and F. Hernandez, Surgical treatment of chronic inflammatory bowel disease in children, Pediatric Surgery International, vol.20, issue.4, pp.385-90, 2011.
DOI : 10.1007/s00383-004-1232-5

J. Allegretti and M. Hamilton, Restoring the gut microbiome for the treatment of inflammatory bowel diseases, World Journal of Gastroenterology, vol.20, issue.13, pp.3468-74, 2014.
DOI : 10.3748/wjg.v20.i13.3468

W. Sandborn, P. Rutgeerts, and B. Feagan, Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab, Gastroenterology, vol.137, issue.4, pp.1250-60, 2009.
DOI : 10.1053/j.gastro.2009.06.061

M. Chaparro, P. Burgueño, and E. Iglesias, Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre study, Alimentary Pharmacology & Therapeutics, vol.55, issue.2, pp.275-83, 2012.
DOI : 10.1136/gut.2005.090316

N. Williet, C. Pillot, and A. Oussalah, Incidence of and impact of medications on colectomy in newly diagnosed ulcerative colitis in the era of biologics, Inflammatory Bowel Diseases, vol.132, issue.9, pp.1641-1647, 2012.
DOI : 10.1053/j.gastro.2006.11.015

R. Cannom, A. Kaiser, and G. Ault, Inflammatory bowel disease in the United States from 1998 to 2005: has infliximab affected surgical rates?, Am Surg, vol.75, pp.976-80, 2009.

D. Turner, S. Travis, and A. Griffiths, Consensus for Managing Acute Severe Ulcerative Colitis in Children: A Systematic Review and Joint Statement From ECCO, ESPGHAN and the Porto IBD Working Group of ESPGHAN, The American Journal of Gastroenterology, vol.53, issue.4, pp.574-88, 2011.
DOI : 10.1097/00005176-199901000-00013

B. Feagan, P. Rutgeerts, and B. Sands, Induction and maintenance therapy with vedolizumab, a novel biologic therapy for ulcerative colitis, Gastroenterol Hepatol, vol.10, pp.64-70, 2014.

S. Paul and X. Roblin, Tofacitinib in active ulcerative colitis, N Engl J Med, vol.367, 2012.

T. Lobatón, S. Vermeire, and G. Van-assche, Review article: anti-adhesion therapies for inflammatory bowel disease, Alimentary Pharmacology & Therapeutics, vol.359, issue.Suppl. 1, pp.579-94, 2014.
DOI : 10.1016/S0140-6736(02)07374-9

H. Herfarth, M. Osterman, and K. Isaacs, Efficacy of methotrexate in ulcerative colitis, Inflammatory Bowel Diseases, vol.16, issue.8, pp.1421-1451, 2010.
DOI : 10.1097/00042737-200409000-00018

S. Willot, A. Noble, and C. Deslandres, Methotrexate in the treatment of inflammatory bowel disease: an 8-year retrospective study in a Canadian pediatric IBD center

J. Shim, Gut Microbiota in Inflammatory Bowel Disease, Pediatric Gastroenterology, Hepatology & Nutrition, vol.16, issue.1, pp.17-21, 2013.
DOI : 10.5223/pghn.2013.16.1.17

J. Shen, Z. Zuo, and A. Mao, Effect of Probiotics on Inducing Remission and Maintaining Therapy in Ulcerative Colitis, Crohn??s Disease, and Pouchitis, Inflammatory Bowel Diseases, vol.96, issue.3, pp.21-35, 2014.
DOI : 10.1111/j.1572-0241.2001.04139.x

S. Kunde, A. Pham, and S. Bonczyk, Safety, Tolerability, and Clinical Response After Fecal Transplantation in Children and Young Adults With Ulcerative Colitis, Journal of Pediatric Gastroenterology and Nutrition, vol.56, issue.6, pp.597-601, 2013.
DOI : 10.1097/MPG.0b013e318292fa0d

A. Ferguson, D. Sedgwick, and J. Drummond, Morbidity of juvenile onset inflammatory bowel disease: effects on education and employment in early adult life., Gut, vol.35, issue.5, pp.665-673, 1994.
DOI : 10.1136/gut.35.5.665

M. Lutgens, M. Van-oijen, and G. Van-der-heijden, Declining Risk of Colorectal Cancer in Inflammatory Bowel Disease, Inflammatory Bowel Diseases, vol.133, issue.4, pp.789-99, 2013.
DOI : 10.1053/j.gastro.2007.08.001

V. Annese, M. Daperno, and M. Rutter, European evidence based consensus for endoscopy in inflammatory bowel disease, Journal of Crohn's and Colitis, vol.90, issue.Suppl. 1, pp.982-1018, 2013.
DOI : 10.1002/bjs.4007

A. Dabadie, M. Bellaiche, and J. Cardey, Mise au point??: ??volution des indications de la coloscopie chez l???enfant en 2012, Archives de P??diatrie, vol.19, issue.11, pp.1247-51, 2012.
DOI : 10.1016/j.arcped.2012.08.005

J. Satsangi, M. Silverberg, and S. Vermeire, The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications, Gut, vol.55, issue.6, pp.749-53, 2006.
DOI : 10.1136/gut.2005.082909

N. Gonsalves, Food Allergies and Eosinophilic Gastrointestinal Illness, Gastroenterology Clinics of North America, vol.36, issue.1, pp.75-91, 2007.
DOI : 10.1016/j.gtc.2007.01.003

F. Alvarez, P. Berg, and F. Bianchi, International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis, Journal of Hepatology, vol.31, issue.5, pp.929-967, 1999.
DOI : 10.1016/S0168-8278(99)80297-9

J. Eaton, J. Talwalkar, and K. Lazaridis, Pathogenesis of Primary Sclerosing Cholangitis and Advances in Diagnosis and Management, Gastroenterology, vol.145, issue.3, pp.521-557, 2013.
DOI : 10.1053/j.gastro.2013.06.052

O. Reilly, D. Malde, D. Duncan, and T. , Review of the diagnosis, classification and management of autoimmune pancreatitis, World J Gastrointest Pathophysiol, vol.5, pp.71-81, 2014.

M. Kovács, K. Müller, and M. Papp, New serological markers in pediatric patients with inflammatory bowel disease, World Journal of Gastroenterology, vol.20, issue.17, pp.4873-82, 2014.
DOI : 10.3748/wjg.v20.i17.4873

F. Seibold, P. Weber, and A. Schöning, Neutrophil antibodies (pANCA) in chronic liver disease and inflammatory bowel disease: do they react with different antigens?, European Journal of Gastroenterology & Hepatology, vol.8, issue.11, pp.1095-100, 1996.
DOI : 10.1097/00042737-199611000-00012

W. Faubion, . Jr, E. Loftus, and W. Sandborn, Pediatric ???PSC-IBD???: A Descriptive Report of Associated Inflammatory Bowel Disease Among Pediatric Patients With PSC, Journal of Pediatric Gastroenterology and Nutrition, vol.33, issue.3, pp.296-300, 2001.
DOI : 10.1097/00005176-200109000-00013

D. Haens, G. Sartor, R. Silverberg, and M. , Future directions in inflammatory bowel disease management, Journal of Crohn's and Colitis, vol.5, issue.Suppl. 2, pp.726-760, 2014.
DOI : 10.1371/journal.pone.0013085

E. Personnes and . Iii, Etude comparative rétrospective sur les RCH de l'enfant associées ou non à des maladies auto-immunes", ne relève pas du champ d'application de la loi sur les recherches biomédicales portant sur la personne humaine